| Database ID | Agent | Target | Cancer Type | Detail |
| DB00811 | LY293111 | Leukotriene B4 receptor 1 | non small cell lung cancer | view |
| DB00812 | U31287 | Receptor proteintyrosine kinase erbB3 | advanced solid tumors | view |
| DB00813 | bevacizumab | Vascular endothelial growth factor | malignant pleural mesothelioma | view |
| DB00814 | erlotinib | Epidermal growth factor receptor | lung cancer | view |
| DB00815 | erlotinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00816 | PF299804 | epidermal growth factor receptors (HER) 1 (EGFR), human epidermal growth factor receptor 2, and HER4 | advanced solid tumors | view |
| DB00817 | crizotinib | Hepatocyte growth factor receptor, ALK, ROS1 | Inflammatory myofibroblastic tumor | view |
| DB00818 | IPI504 | Heat shock protein HSP 90 | non small cell lung cancer | view |
| DB00819 | neratinib | mRNA of human epidermal growth factor receptor 2
Vascular endothelial growth factor receptor 2
Epidermal growth factor receptor | advanced solid tumors | view |
| DB00820 | CI1033 | Epidermal growth factor receptor
Receptor proteintyrosine kinase erbB2
AKT1 protein kinase
Receptor proteintyrosine kinase erbB4 | non small cell lung cancer | view |
| DB00821 | erlotinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00822 | gefitinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00823 | ramucirumab | Vascular endothelial growth factor receptor 2 | non small cell lung cancer | view |
| DB00824 | erlotinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00825 | crizotinib | Hepatocyte growth factor receptor, ALK, ROS1 | non small cell lung cancer | view |